136 related articles for article (PubMed ID: 8844623)
1. Improved detection of replication-competent retrovirus.
Forestell SP; Dando JS; Böhnlein E; Rigg RJ
J Virol Methods; 1996 Jul; 60(2):171-8. PubMed ID: 8844623
[TBL] [Abstract][Full Text] [Related]
2. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
Printz M; Reynolds J; Mento SJ; Jolly D; Kowal K; Sajjadi N
Gene Ther; 1995 Mar; 2(2):143-50. PubMed ID: 7719931
[TBL] [Abstract][Full Text] [Related]
3. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K
Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.
Kubo S; Haga K; Tamamoto A; Palmer DJ; Ng P; Okamura H; Kasahara N
Mol Ther; 2011 Jan; 19(1):76-82. PubMed ID: 20808291
[TBL] [Abstract][Full Text] [Related]
5. Production of high-titer retroviral vectors and detection of replication-competent retroviruses.
Kim YS; Lim HK; Kim KJ
Mol Cells; 1998 Feb; 8(1):36-42. PubMed ID: 9571629
[TBL] [Abstract][Full Text] [Related]
6. Endogenous murine leukemia virus DNA sequences in murine cell lines: implications for gene therapy safety testing by PCR.
Allan DS; De Koven A; Wild A; Kamel-Reid S; Dubé ID
Leuk Lymphoma; 1996 Oct; 23(3-4):375-81. PubMed ID: 9031120
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.
Martineau D; Klump WM; McCormack JE; DePolo NJ; Kamantigue E; Petrowski M; Hanlon J; Jolly DJ; Mento SJ; Sajjadi N
Hum Gene Ther; 1997 Jul; 8(10):1231-41. PubMed ID: 9215740
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors.
Wilson CA; Ng TH; Miller AE
Hum Gene Ther; 1997 May; 8(7):869-74. PubMed ID: 9143913
[TBL] [Abstract][Full Text] [Related]
9. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.
Chen J; Reeves L; Cornetta K
Hum Gene Ther; 2001 Jan; 12(1):61-70. PubMed ID: 11177543
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
11. An improved method for detection of replication-competent retrovirus in retrovirus vector products.
Uchida E; Sato K; Iwata A; Ishii-Watabe A; Mizuguchi H; Hikata M; Murata M; Yamaguchi T; Hayakawa T
Biologicals; 2004 Sep; 32(3):139-46. PubMed ID: 15536044
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
13. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
Lee ES; Jin SY; Kang BK; Jung YT
J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
[TBL] [Abstract][Full Text] [Related]
14. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.
Logg CR; Tai CK; Logg A; Anderson WF; Kasahara N
Hum Gene Ther; 2001 May; 12(8):921-32. PubMed ID: 11387057
[TBL] [Abstract][Full Text] [Related]
15. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
16. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
17. A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.
Aloia AL; Duffy L; Pak V; Lee KE; Sanchez-Martinez S; Derse D; Heidecker G; Cornetta K; Rein A
Gene Ther; 2013 Feb; 20(2):169-76. PubMed ID: 22402321
[TBL] [Abstract][Full Text] [Related]
18. Detection of replication competent retrovirus and lentivirus.
Sastry L; Cornetta K
Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
[TBL] [Abstract][Full Text] [Related]
19. Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors.
Lamers CH; Willemsen RA; van Elzakker PM; Gratama JW; Debets R
J Immunother; 2009 Apr; 32(3):272-9. PubMed ID: 19242373
[TBL] [Abstract][Full Text] [Related]
20. In vivo analysis of a new lacZ retrovirus vector suitable for cell lineage marking in avian and other species.
Mikawa T; Fischman DA; Dougherty JP; Brown AM
Exp Cell Res; 1991 Aug; 195(2):516-23. PubMed ID: 2070832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
